Poly(D,L-lactide-co-glycolide), ester terminated, Mw 50,000-75,000

Code: 430471-1G D2-231

Application

PLGA polymers find uses in the production of biodegradable medical sutures and for controlled drug release. PLGA microspheres have been reported for use in contro...


read more

Your Price
£103.40 1G
£124.08 inc. VAT
REQUEST

Application

PLGA polymers find uses in the production of biodegradable medical sutures and for controlled drug release. PLGA microspheres have been reported for use in controlled release of human growth hormone. Thin membranes of blended polymers constituting of PLGA/polycaprolactone/β-tricalcium phosphate have been used in guided bone regeneration.

Features and Benefits

Controlled release of bioactive agents, sutures and bioabsorbable implantable devices.

General description

Characteristic properties of ester terminated poly(D,L-lactide-co-glycolide) (PLGA) are in vivo biodegradability, tunable drug release profile and very high encapsulation capacity.

Legal Information

Lactel is a registered trademark of Durect Corp.

Packaging

1, 5 g in glass bottle

Physical form

Biocompatible, biodegradable polymer.

degradation timeframe﹤6 months
feed ratiolactide:glycolide 85:15
formamorphous
mol wtMw 50,000-75,000
Quality Level100
SMILES stringOCC(O)=O.CC(O)C(O)=O
solubilityethyl acetate, chloroform, acetone and THF: soluble
storage temp.2-8°C
transition tempTg 45-50 °C
viscosity0.55-0.75 dL/g, 0.1 % (w/v) in chloroform(25 °C)
Code
Description
Unit Size
List Price
Qty
430471-5G
Poly(D,L-lactide-co-glycolide), ester terminated, Mw 50,000-75,000

Unit:5G
List Price: £355.10
Source:List Price
ADD
Cas Number26780-50-7
This product has met the following criteria: